Understand the difference between GLP and GLP-1, and how GLP-1 treatment plans may be considered by licensed providers as part of your personalized wellness care.
Disclaimer: This content is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider. Eden connects individuals with licensed providers who offer personalized treatment advice and plans.
In conversations about wellness and metabolic health, “GLP” and “GLP-1” are terms that may come up when discussing energy, blood sugar, and overall health support. But what do they actually mean, and how are they different?
Understanding how GLP and GLP-1 function in the body may help you have more productive conversations with a licensed healthcare provider. Eden connects individuals with independent, licensed providers who evaluate whether certain treatment plans, including FDA-approved GLP-1 medications, may be appropriate based on your individual health history.
GLP stands for glucagon-like peptides, a group of hormones produced in the digestive tract. These hormones may help regulate processes like:
One key member of this group is GLP-1 (glucagon-like peptide-1). This hormone may help signal the pancreas to release insulin and may play a role in regulating the body's food intake. Because of these actions, GLP-1 is the focus of many clinical studies examining its impact on metabolic function and blood glucose levels.
GLP-1 receptor agonists are a class of FDA-approved prescription medications originally developed to treat type 2 diabetes. Some of these medications are also approved for chronic weight management in adults with certain health profiles, such as those with obesity or those who are overweight with weight-related conditions.
These medications are designed to mimic the natural GLP-1 hormone by activating specific receptors in the body, which may support regulated appetite, improved glucose control, and slower digestion in some patients.
Depending on your medical history, a licensed healthcare provider may determine whether a GLP-1 medication is appropriate as part of a comprehensive treatment plan.
GLP-1 receptor agonists:
These medications are not intended for general cosmetic weight loss and may not be suitable for everyone. Treatment suitability must be evaluated by a licensed provider based on individual health needs.
{{primary-cta}}
If you’re exploring new ways to support your overall wellness, a conversation with a licensed provider can help determine whether a GLP-1-based treatment plan is medically appropriate for you. While GLP-1 medications are not a standalone solution, some licensed providers may include them as part of broader care plans that include:
Eden helps simplify the process by connecting you to independent, licensed providers who are experienced in managing metabolic health. If determined appropriate, your provider may prescribe an FDA-approved GLP-1 medication and help you track your progress through a personalized care plan.
{{primary-cta}}
Eden is a digital health platform that connects individuals to licensed healthcare providers and state-licensed pharmacies. We do not make treatment decisions, dispense medication, or act as a healthcare provider.
Our platform provides:
All treatment decisions, including medication prescriptions, are made solely by the licensed healthcare provider.
Note: GLP-1 medications are not approved for general wellness, energy enhancement, or cosmetic weight loss. They are only prescribed when medically appropriate based on clinical guidelines and a provider’s judgment.
Understanding the difference between GLP and GLP-1 can help you make more informed decisions about your wellness journey. GLP is a group of naturally occurring hormones, while GLP-1 is a specific hormone with functions that have led to the development of prescription treatments.
GLP-1-based treatment plans may support wellness strategies for eligible individuals under the guidance of a licensed healthcare provider. Eden offers a way to begin that conversation, providing access to expert care and ongoing treatment support when appropriate.
Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing. Prescriptions and a medical evaluation are required for certain products. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns, including side effects. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects or consequences resulting from the use of any suggestions or information provided in this blog.
Eden is not a medical provider or a pharmacy. Eden connects individuals with independent licensed healthcare providers who independently evaluate each patient to determine whether a prescription treatment program is appropriate. All prescriptions are written at the sole discretion of the licensed provider. Medications are filled by independent, state-licensed pharmacies. Eden does not manufacture, own, or dispense any medications. Please consult a licensed healthcare provider before making any medical decisions.
Collins, L., & Costello, R. A. (2024, February 29). Glucagon-Like peptide-1 receptor agonists. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK551568/
